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Purpose: Monte Carlo (MC) methods have the potential to improve the accuracy of 
the dose calculations and are increasingly being recognised as the ‘gold standard’ for 
predicting dose deposition in the patient. Software has been developed that enables 
the transfer of treatment plan information from the treatment planning system (TPS) 
to an MC dose calculation engine. In this study the MC system was validated against 
measurements and TPS calculations in homogeneous and inhomogeneous phantoms 
for a range of different delivery techniques that are commonly used clinically. 
 
Materials: A database of commissioned linear accelerator models (Elekta Precise and 
Varian 2100CD at various energies) has been developed using the EGSnrc/BEAMnrc 
MC software. Planned beam descriptions and CT images can be exported from the 
TPS using the DICOM framework. The information in these files is used to construct 
a plan-specific  accelerator model which allows an accurate calculation of the 
radiation field incident on a constructed patient geometry. The MC dose calculation 
results are converted to absolute dose per-MU using calibration factors recorded using 
the MC commissioning process and treatment dose calculations, and then are 
combined according to the MU settings stored in the exported plan. The result is a 3D 
dose distribution that can be compared with the dose calculations obtained from the 
planning system. The American Association of Physicists in Medicine 
recommendations on external beam dose calculation verification were used when 
designing treatment plans for ion chamber measurements in an acrylic QUASAR 
body phantom (Modus Medical Devices Inc). Existing measurement and TPS data for 
an anthropomorphic pelvis phantom, taken as part of a national dosimetry study, were 
also used to verify the MC dose predictions. 
 
Results: The developed software has successfully produced MC input files for a 
variety of plans exported from Eclipse (Varian Medical Systems), Pinnacle (Philips 
Medical Systems) and Oncentra MasterPlan (Nucletron) planning systems; ranging in 
complexity from single square fields to an 11-field step-and-shoot IMRt treatment. 
The MC dose predictions deviated from the ion chamber measurements most 
significantly in the build-up regions (7.5% nearest the surface). Beyond this region 
there was strong agreement: within 1.6% near heterogeneities and 0.27% otherwise. 
 
Conclusions: The capability of the developed MC software to independently process 
and calculate the dosimetry for radiotherapy treatment plans has been demonstrated. 
Validation of the MC system was shown through comparison with measurements and 
TPS dose calculations in homogeneous and inhomogeneous phantoms. This work is 
the first stage in the development of an independent MC dose calculation system for 
verifying and validating complex radiotherapy treatments such as IMRT. 
